Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
Exicure, Inc. disclosed receipt of a Nasdaq notice due to delayed filing of its Q1 2026 Form 10-Q, which was subsequently filed, restoring compliance. The company is in a transition phase following restructuring, suspension of clinical activities, and is currently exploring strategic alternatives to maximize shareholder value while advancing a clin…